Actively Recruiting
Real-World Study on Diagnosis, Treatment, and Survival in Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in China
Led by The Children's Hospital of Zhejiang University School of Medicine · Updated on 2026-09-10
500
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a national study in China to understand the diagnosis, treatment, and survival outcomes of children with Philadelphia chromosome-positive acute lymphoblastic leukemia Ph ALL. This type of leukemia accounts for 3%-5% of childhood cases and was once linked to poor outcomes. The study focuses on comparing typical Ph ALL with a subtype called CML-like ALL, which shows different biological features and treatment responses. The goal is to improve treatment strategies and survival for affected children using real-world data from multiple medical centers. This retrospective study includes children diagnosed with Ph ALL from 2015 to 2024 who received standardized treatment with tyrosine kinase inhibitors TKIs like imatinib or dasatinib. Patients are grouped into typical Ph ALL and CML-like ALL based on detailed molecular testing. Minimal residual disease MRD is monitored through methods such as flow cytometry and PCR at consistent times during treatment. No new treatments are given as part of the study, which collects and analyzes existing clinical data. Participants medical records are reviewed to assess survival rates, treatment responses, and disease characteristics. The main outcome is overall survival measured up to 10 years from treatment start, along with event-free survival. The study aims to enroll over 500 children and uses strict privacy measures to protect patient data. Findings will help guide personalized treatment and reduce overtreatment risks in CML-like ALL, aiming to enhance long-term health and quality of life for these children.
CONDITIONS
Brief Title
Ph+ ALL in Chinese Children: Diagnosis, Treatment, and Survival
Research Team
A
Aimei Ma
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here